Andreas Hinsen
Partner | Attorney at law
T. +41 58 510 92 50 | +41 79 792 78 12
andreas.hinsen@advestra.ch
LinkedIn
Andreas Hinsen's practice focuses on domestic and cross-border M&A transactions, corporate governance, restructurings as well as general corporate and stock exchange laws.
Andreas has broad experience in private equity and venture capital transactions and has advised on a wide range of corporate transactions, including joint ventures, internal restructurings, shareholder agreements, growth capital investments and public-to-private deals. He also frequently advises on general corporate law matters and real estate transactions.
Prior to joining Advestra, Andreas worked at two leading Swiss law firms as well as a leading New York law firm.
Andreas is ranked by both IFLR1000 and Legal500 and listed as rising star by Expert Guides in the areas of Corporate/M&A/Private Equity since 2021.
- Advising the sellers on the sale of IntiQuan AG to ProductLife Group
- Advising ENR Russia Invest SA on the public tender offer of its majority shareholder Valartis
- Advising eMolecules Inc. and Avista Healthcare Partners on the acquisition of Synple Chem AG
- Advising funds affiliated with Perceptive Advisors on the acquisition of a portfolio of preclinical assets and launch of Neurosterix
- Advising the shareholders of RMB Group on the strategic partnership with eevolve
- Advising Marc O'Polo on the acquisition of the Swiss business from distribution partner Bollag-Guggenheim
- Advising Glencore, CPP Investments and BCI, as shareholders, in Viterra Ltd.'s business combination with Bunge Ltd
- Advising Catalyst Pharmaceuticals on license to vamorolone and equity investment in Santhera Pharmaceuticals
- Advising Ironwood Pharmaceuticals on its public tender offer for VectivBio
- Advising Belden, Inc. on the acquisition of NetModule
- Advising a private equity fund in the acquisition of an office complex in Geneva
- Advising the finance parties in relation to the acquisition of Adcubum
- Advising the European Investment Bank in a quasi-equity financing agreement with Xeltis
- Advising the founders of Wabion on its sale to Accenture
- Advising a private investor on the acquisition of the economic interest in Credit Suisse's real estate leasing portfolio
- Advising Folli Follie Group in its restructuring
- Advising FLAGA Suisse on the acquisition of the Liquified Petroleum Gas business of SOCAR in Switzerland
- Advising RRJ on the acquisition of gategroup Holding
- Partner at Advestra (since 2023)
- Local Partner at Loyens & Loeff (2019-2022)
- Associate at Lenz & Staehelin (2015-2020)
- Visiting Lawyer at Sullivan & Cromwell (2013-2014)
- Georgetown Law School: LL.M. (2013)
- Admission to the Swiss Bar (2010)
- University of Basel: lic. iur. (2008)
- Zurich Bar Association (ZAV)
- Swiss Bar Association (SAV)
- AIJA (International Association of Young Lawyers)
- Member of the Foundation Board of Kronstein Foundation
- Switzerland: An Introduction to Corporate/M&A in Chambers & Partners Global Guide 2022 (with Marco Toni)
- GameStop or Stop the Game?, in GesKR 2/2021
- Untrue or Incomplete Information in Offer Prospectus (with Hans-Jakob Diem), CapLaw 2018-32
- Die zeitliche und sachliche Wirkung des Déchargebeschlusses, in GesKR 4/2014
- Empty Voting and similar Instruments (with Rolf Watter), in Mergers & Acquisitions XI
- German
- English
- All Swiss courts
- Advestra advises the shareholders of Viterra Limited in the merger with Bunge Global
- Advestra advises LOGEX on the acquisition of INMED
- Advestra advises the sellers on the sale of IntiQuan AG to ProductLife Group
- Advestra advises ENR Russia Invest SA on the public tender offer of its majority shareholder Valartis
- Advestra advises eMolecules Inc. and Avista Healthcare Partners on the acquisition of Synple Chem AG
- Advestra advises Cactus Life Sciences on the acquisition of nspm and eluSCIdate
- Advestra advises funds affiliated with Perceptive Advisors on the launch of Neurosterix
- Advestra advises the shareholders of RMB Group on the strategic partnership with eevolve
- Advestra advises Marc O'Polo on the acquisition of the Swiss business from distribution partner Bollag-Guggenheim
- Advestra advises Catalyst Pharmaceuticals on license to vamorolone and equity investment in Santhera Pharmaceuticals